Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

National Institute of Environmental Health Sciences

Use this QR code to view the newest version of this document
Use this QR code to view the newest version of this document

Your Environment. Your Health.

Publication Detail

Title: Human placenta does not Reduce AZT (zidovudine) to 3'-amino-3'-deoxythymidine.

Authors: Plessinger, M A; Boal, J H; Miller, R K

Published In Proc Soc Exp Biol Med, (1997 Jul)

Abstract: Human placental tissue and human trophoblast cells (JAr) were examined after exposure to the anti-HIV nucleoside analog AZT (Zidovudine) for the presence of 3'-amino-3'-deoxythymidine (AMT), a toxic catabolite. Placental cells were exposed to 7.6 mM AZT for 48 hr, and placental lobular tissue was perfused with 3.8 mM AZT for 14 hr. Cell homogenates were prepared, and supernatants were subjected to HPLC analysis. Despite large cellular concentrations of AZT, AMT was not detected in any of the samples analyzed. Exposure of JAr cells to this concentration of AZT produces a 72% inhibition of cell proliferation when compared with unexposed controls. Based upon the results of the current study, AMT was not formed by placental cells exposed to AZT and, thus, not a mechanism for toxicity after in vitro exposure to AZT.

PubMed ID: 9207859 Exiting the NIEHS site

MeSH Terms: Chromatography, High Pressure Liquid; Culture Techniques; Dideoxynucleosides/metabolism*; Female; Humans; Placenta/metabolism*; Pregnancy; Tumor Cells, Cultured; Zidovudine/pharmacokinetics*

Back
to Top